|
|
 
|
|
|
Full Text: 
|
|
|
|
¿µ³²ÀÇ´ëÇмúÁö Yeungnam Univ J Med 2018;35(1):17-26
|
|
REVIEW ARTICLE
|
|
Recent updates in transcatheter aortic valve implantation |
|
|
|
Jeonghwan Cho1, Ung Kim2
|
1Division of Cardiology, Daegu Veterans Hospital; 2Division of Cardiology, Department of Internal Medicine,
Yeungnam University Medical Center, Daegu, Korea
|
|
|
|
Corresponding Author: Ung Kim, Division of Cardiology,
Department of Internal Medicine, Yeungnam University
Medical Center, 170, Hyunchung-ro, Namgu, Daegu
42415, Korea
|
|
Tel: +82-53-620-3832, Fax: +82-53-654-8386
|
|
E-mail: woongwa@yu.ac.kr
|
|
Received: April 18, 2018, Revised: May 8, 2018
Accepted: May 29, 2018
|
|
|
|
Abstract
|
|
|
|
Transcatheter aortic valve implantation (TAVI) has evolved from a challenging intervention to a standardized,
simple, and streamlined procedure with over 350,000 procedures performed in over 70 countries. It is now
a novel alternative to surgical aortic valve replacement in patients with intermediate surgical risk and its
indications have been expanded to cohorts with bicuspid aortic valves, low surgical risk, and younger age
and fewer comorbidities. Attention should be paid to further reducing remaining complications, such as paravalvular
aortic regurgitation, conduction abnormalities, cardiac tamponade, and stroke. The aim of this review
is to provide an overview on the rapidly changing field of TAVI treatment and to explore past achievements,
current issues, and future perspectives of this treatment modality.
|
|
|
|
Key Words: Keywords: Aortic valve stenosis; Transcatheter aortic valve implantation; Surgery; Indications
|
|
|
|
References |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
